Literature DB >> 33945628

Histopathologic synoptic reporting of invasive melanoma: How reliable are the data?

Laura A Taylor1, Megan M Eguchi2, Lisa M Reisch3, Andrea C Radick3, Hannah Shucard3, Kathleen F Kerr3, Michael W Piepkorn4,5, Stevan R Knezevich6, David E Elder7, Raymond L Barnhill8,9,10, Joann G Elmore2.   

Abstract

BACKGROUND: Synoptic reporting is recommended by many guideline committees to encourage the thorough histologic documentation necessary for optimal management of patients with melanoma.
METHODS: One hundred fifty-one pathologists from 40 US states interpreted 41 invasive melanoma cases. For each synoptic reporting factor, the authors identified cases with "complete agreement" (all participants recorded the same value) versus any disagreement. Pairwise agreement was calculated for each case as the proportion of pairs of responses that agreed, where paired responses were generated by the comparison of each reviewer's response with all others.
RESULTS: There was complete agreement among all reviewers for 22 of the 41 cases (54%) on Breslow thickness dichotomized at 0.8 mm, with pairwise agreement ranging from 49% to 100% across the 41 cases. There was complete agreement for "no ulceration" in 24 of the 41 cases (59%), with pairwise agreement ranging from 42% to 100%. Tumor transected at base had complete agreement for 26 of the 41 cases (63%), with pairwise agreement ranging from 31% to 100%. Mitotic rate, categorized as 0/mm2 , 1/mm2 , or 2/mm2 , had complete agreement for 17 of the 41 cases (41%), with pairwise agreement ranging from 36% to 100%. Regression saw complete agreement for 14 of 41 cases (34%), with pairwise agreement ranging from 40% to 100%. Lymphovascular invasion, perineural invasion, and microscopic satellites were rarely reported as present. Respectively, these prognostic factors had complete agreement for 32 (78%), 37 (90%), and 18 (44%) of the 41 cases, and the ranges of pairwise agreement were 47% to 100%, 70% to 100%, and 53% to 100%, respectively.
CONCLUSIONS: These findings alert pathologists and clinicians to the problem of interobserver variability in recording critical prognostic factors. LAY
SUMMARY: This study addresses variability in the assessment and reporting of critical characteristics of invasive melanomas that are used by clinicians to guide patient care. The authors characterize the diagnostic variability among pathologists and their reporting methods in light of recently updated national guidelines. Results demonstrate considerable variability in the diagnostic reporting of melanoma with regard to the following: Breslow thickness, mitotic rate, ulceration, regression, and microscopic satellites. This work serves to alert pathologists and clinicians to the existence of variability in reporting these prognostic factors.
© 2021 American Cancer Society.

Entities:  

Keywords:  dermatopathology; interobserver variability; melanocytic skin lesions; melanoma; synoptic reports

Mesh:

Year:  2021        PMID: 33945628      PMCID: PMC8753995          DOI: 10.1002/cncr.33612

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  32 in total

1.  Observer variation in the measurement of Breslow depth and Clark's level in thin cutaneous malignant melanoma.

Authors:  P S Colloby; K P West; A Fletcher
Journal:  J Pathol       Date:  1991-03       Impact factor: 7.996

2.  Template-based synoptic reports improve the quality of pathology reports of prostatectomy specimens.

Authors:  Konrad Aumann; Dominic Amann; Vera Gumpp; Dieter Hauschke; Gian Kayser; Annette M May; Ulrich Wetterauer; Martin Werner
Journal:  Histopathology       Date:  2012-01-25       Impact factor: 5.087

3.  Guidelines of care for the management of primary cutaneous melanoma.

Authors:  Susan M Swetter; Hensin Tsao; Christopher K Bichakjian; Clara Curiel-Lewandrowski; David E Elder; Jeffrey E Gershenwald; Valerie Guild; Jane M Grant-Kels; Allan C Halpern; Timothy M Johnson; Arthur J Sober; John A Thompson; Oliver J Wisco; Samantha Wyatt; Shasa Hu; Toyin Lamina
Journal:  J Am Acad Dermatol       Date:  2018-11-01       Impact factor: 11.527

4.  The MPATH-Dx reporting schema for melanocytic proliferations and melanoma.

Authors:  Michael W Piepkorn; Raymond L Barnhill; David E Elder; Stevan R Knezevich; Patricia A Carney; Lisa M Reisch; Joann G Elmore
Journal:  J Am Acad Dermatol       Date:  2013-10-28       Impact factor: 11.527

5.  Achieving consensus for the histopathologic diagnosis of melanocytic lesions: use of the modified Delphi method.

Authors:  Patricia A Carney; Lisa M Reisch; Michael W Piepkorn; Raymond L Barnhill; David E Elder; Stevan Knezevich; Berta M Geller; Gary Longton; Joann G Elmore
Journal:  J Cutan Pathol       Date:  2016-07-01       Impact factor: 1.587

6.  Structured reporting ensures complete content and quick detection of essential data in pathology reports of oncological breast resection specimens.

Authors:  Konrad Aumann; Kathrin Niermann; Jasmin Asberger; Ulrich Wellner; Peter Bronsert; Thalia Erbes; Dieter Hauschke; Elmar Stickeler; Gerald Gitsch; Gian Kayser; Martin Werner
Journal:  Breast Cancer Res Treat       Date:  2016-04-08       Impact factor: 4.872

7.  Histomorphologic assessment and interobserver diagnostic reproducibility of atypical spitzoid melanocytic neoplasms with long-term follow-up.

Authors:  Pedram Gerami; Klaus Busam; Alistair Cochran; Martin G Cook; Lyn M Duncan; David E Elder; Douglas R Fullen; Joan Guitart; Philip E LeBoit; Martin C Mihm; Victor G Prieto; Michael S Rabkin; Richard A Scolyer; Xiaowei Xu; Sook Jung Yun; Roxana Obregon; Pedram Yazdan; Chelsea Cooper; Bing Bing Weitner; Alfred Rademaker; Raymond L Barnhill
Journal:  Am J Surg Pathol       Date:  2014-07       Impact factor: 6.394

8.  Influence of variability in assessment of Breslow thickness, mitotic rate and ulceration among US pathologists interpreting invasive melanoma, for the purpose of AJCC staging.

Authors:  Laura Taylor; Kyle Hood; Lisa Reisch; Joann Elmore; Michael Piepkorn; Raymond Barnhill; Stevan Knezevich; Andrea Radick; David Elder
Journal:  J Cutan Pathol       Date:  2018-05-29       Impact factor: 1.587

9.  Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma.

Authors:  Mary-Ann El Sharouni; Karina Aivazian; Arjen J Witkamp; Vigfús Sigurdsson; Carla H van Gils; Richard A Scolyer; John F Thompson; Paul J van Diest; Serigne N Lo
Journal:  JAMA Dermatol       Date:  2021-02-01       Impact factor: 10.282

Review 10.  The effects of implementing synoptic pathology reporting in cancer diagnosis: a systematic review.

Authors:  Caro E Sluijter; Luc R C W van Lonkhuijzen; Henk-Jan van Slooten; Iris D Nagtegaal; Lucy I H Overbeek
Journal:  Virchows Arch       Date:  2016-04-21       Impact factor: 4.064

View more
  2 in total

1.  Histopathological diagnosis of cutaneous melanocytic lesions: blinded and nonblinded second opinions offer similar improvement in diagnostic accuracy.

Authors:  Kathleen F Kerr; Gary M Longton; Lisa M Reisch; Andrea C Radick; Megan M Eguchi; Hannah L Shucard; Margaret S Pepe; Michael W Piepkorn; David E Elder; Raymond L Barnhill; Joann G Elmore
Journal:  Clin Exp Dermatol       Date:  2022-06-22       Impact factor: 4.481

2.  Reproducibility and Feasibility of Classification and National Guidelines for Histological Diagnosis of Canine Mammary Gland Tumours: A Multi-Institutional Ring Study.

Authors:  Serenella Papparella; Maria Ines Crescio; Valeria Baldassarre; Barbara Brunetti; Giovanni P Burrai; Cristiano Cocumelli; Valeria Grieco; Selina Iussich; Lorella Maniscalco; Francesca Mariotti; Francesca Millanta; Orlando Paciello; Roberta Rasotto; Mariarita Romanucci; Alessandra Sfacteria; Valentina Zappulli
Journal:  Vet Sci       Date:  2022-07-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.